propidium has been researched along with Breast Cancer in 31 studies
Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.
Excerpt | Relevance | Reference |
---|---|---|
"A pulsed (17 nanoseconds) Nd:YAG laser (1064 nm) was used to inject impermeable dyes (propidium iodide andiodide and merocyanine 540) and a plasmid (pEGFP-N1) encoding green fluorescent protein (GFP) into human breast adenocarcinoma cells (MCF-7)." | 3.72 | Laser-assisted microinjection into targeted animal cells. ( Gupta, PK; Mohanty, SK; Sharma, M, 2003) |
"LCC2, an estradiol-independent tamoxifen (Tax)-resistant subline of MCF-7 human breast cancer cell line, is resistant relatively towards Tax and methotrexate (Mtx)." | 3.71 | Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells. ( Goldfinger, N; Lilling, G; Nordenberg, J; Peller, S; Rotter, V; Sidi, Y, 2002) |
" Staining FNA samples with CycleTEST propidium iodide reagents demonstrated improved sensitivity in the recognition of near diploid and near tetraploid aneuploid populations: 9 of 20 resolvable aneuploid DNA stemlines identified in FNA suspensions were not detected or clearly resolved in M/EWC preparations." | 3.68 | Improved sensitivity and resolution in the flow cytometric DNA analysis of human solid tumor specimens. Use of in vitro fine-needle aspiration and uniform staining reagents. ( Bach, BA; Edinger, MG; Knape, WA; Tubbs, RR, 1991) |
"The clinical efficacy of conventional chemotherapeutic agent, methotrexate (MTX), can be limited by its very short plasma half-life, the drug resistance, and the high dosage required for cancer cell suppression." | 1.40 | Inorganic nanovehicle targets tumor in an orthotopic breast cancer model. ( Choi, G; Choy, JH; Kwon, OJ; Oh, Y; Yun, CO, 2014) |
"MCF-7 breast cancer cell lines and heterogeneous cell populations mixed with MCF-7 cells and human peripheral blood lymphocytes (PBL) were fixed with 1% paraformaldehyde and permeabilized with 100% methanol." | 1.31 | Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7). ( Han, KT; Kim, SP; Lee, GS; Namkoong, SE; Rha, JG; Ryu, KS, 2002) |
"Lycopene treatment markedly reduced the IGF-I stimulation of tyrosine phosphorylation of insulin receptor substrate 1 and binding capacity of the AP-1 transcription complex." | 1.31 | Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. ( Amir, H; Danilenko, M; Fishman, D; Giat, Y; Karas, M; Koifmann, A; Levy, J; Nahum, A; Segal, S; Sharoni, Y, 2000) |
"The comedo histologic subtype had an aneuploidy rate of 39% (9 of 23); noncomedo subtypes had an aneuploidy rate of 19% (5 of 27), p=ns." | 1.31 | Flow cytometric DNA analysis of specimen mammography-guided fine-needle aspirates of ductal carcinoma in situ. ( DeBloom, JR; Stewart, CC; Stomper, PC; Winston, JS, 2000) |
"This study utilized MDA-MB-175-VII breast carcinoma cells deprived of oxygen for up to 11 d to simulate intratumoral hypoxia, and 10 human breast tumors and mouse-human breast tumor xenografts disassociated by mechanical or enzymatic means." | 1.30 | Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors. ( Avner, B; Bolton, WE; Freeman, JW; Hanly, A; Healy, SF; Hurst, JM; Koester, SK; Mies, C; O'Brien, MC; Raney, SR; Snow, C, 1997) |
"Previous studies have suggested that multiple myeloma (MM) cells express estrogen receptors (ER)." | 1.30 | Anti-estrogens induce apoptosis of multiple myeloma cells. ( Anderson, KC; Chauhan, D; Ogata, A; Teoh, G; Treon, SP; Urashima, M; Webb, IJ, 1998) |
"Unfixed MDA-468 cells, a human breast cancer cell line, were temporarily permeabilized with lysolecithin." | 1.29 | Isolation of high quality mRNA from a discrete cell cycle population identified using a nonvital dye and fluorescence activated sorting. ( Church, JG; Reilly, BD; Stapleton, EA, 1993) |
"Eight cases of primary breast carcinoma were studied for evidence of heterogeneity by flow cytometry using propidium iodide staining of DNA." | 1.27 | Heterogeneity of breast carcinomas determined by flow cytometric analysis. ( McDivitt, RW; Meyer, JS; Prey, MU; Stone, KR, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.23) | 18.7374 |
1990's | 10 (32.26) | 18.2507 |
2000's | 11 (35.48) | 29.6817 |
2010's | 5 (16.13) | 24.3611 |
2020's | 4 (12.90) | 2.80 |
Authors | Studies |
---|---|
Mukundan, S | 1 |
Bell, J | 1 |
Teryek, M | 1 |
Hernandez, C | 1 |
Love, AC | 1 |
Parekkadan, B | 1 |
Chan, LL | 1 |
Ismail, NZ | 1 |
Md Saad, S | 1 |
Adebayo, IA | 1 |
Md Toha, Z | 1 |
Abas, R | 1 |
Mohamad Zain, NN | 1 |
Arsad, H | 1 |
Xulu, K | 1 |
Duarte, R | 1 |
Augustine, T | 1 |
Benassi, JC | 1 |
Barbosa, FAR | 1 |
Candiotto, G | 1 |
Grinevicius, VMAS | 1 |
Filho, DW | 1 |
Braga, AL | 1 |
Pedrosa, RC | 1 |
Ebrahimi Nigjeh, S | 1 |
Yusoff, FM | 1 |
Mohamed Alitheen, NB | 1 |
Rasoli, M | 1 |
Keong, YS | 1 |
Omar, AR | 1 |
Choi, G | 1 |
Kwon, OJ | 1 |
Oh, Y | 1 |
Yun, CO | 1 |
Choy, JH | 1 |
Bagheri, F | 1 |
Safarian, S | 1 |
Eslaminejad, MB | 1 |
Sheibani, N | 1 |
Nikhil, K | 1 |
Sharan, S | 1 |
Singh, AK | 1 |
Chakraborty, A | 1 |
Roy, P | 1 |
Mobarra, N | 1 |
Shafiee, A | 1 |
Rad, SM | 1 |
Tasharrofi, N | 1 |
Soufi-Zomorod, M | 1 |
Hafizi, M | 1 |
Movahed, M | 1 |
Kouhkan, F | 1 |
Soleimani, M | 1 |
Choi, YS | 1 |
Kim, HB | 1 |
Kim, SH | 1 |
Choi, J | 1 |
Park, JK | 1 |
Mirjolet, JF | 1 |
Didelot, C | 1 |
Barberi-Heyob, M | 1 |
Merlin, JL | 1 |
Lee, GS | 1 |
Ryu, KS | 1 |
Rha, JG | 1 |
Kim, SP | 1 |
Namkoong, SE | 1 |
Han, KT | 1 |
Mohanty, SK | 1 |
Sharma, M | 1 |
Gupta, PK | 1 |
Krotkiewski, M | 1 |
Przybyszewska, M | 1 |
Janik, P | 1 |
Church, JG | 1 |
Stapleton, EA | 1 |
Reilly, BD | 1 |
Ciancio, G | 1 |
Pollack, A | 1 |
Block, NL | 1 |
Pellicciari, C | 1 |
Mangiarotti, R | 1 |
Bottone, MG | 1 |
Danova, M | 1 |
Wang, E | 1 |
O'Brien, MC | 1 |
Healy, SF | 1 |
Raney, SR | 1 |
Hurst, JM | 1 |
Avner, B | 1 |
Hanly, A | 1 |
Mies, C | 1 |
Freeman, JW | 1 |
Snow, C | 1 |
Koester, SK | 1 |
Bolton, WE | 1 |
Treon, SP | 1 |
Teoh, G | 1 |
Urashima, M | 1 |
Ogata, A | 1 |
Chauhan, D | 1 |
Webb, IJ | 1 |
Anderson, KC | 1 |
Leers, MP | 1 |
Schutte, B | 1 |
Theunissen, PH | 1 |
Ramaekers, FC | 1 |
Nap, M | 1 |
Sabe, I | 1 |
Andritsch, I | 1 |
Mangoud, A | 1 |
Awad, AS | 1 |
Khalifa, A | 1 |
Krishan, A | 1 |
Johansson, MC | 1 |
Baldetorp, B | 1 |
Oredsson, SM | 1 |
Karas, M | 1 |
Amir, H | 1 |
Fishman, D | 1 |
Danilenko, M | 1 |
Segal, S | 1 |
Nahum, A | 1 |
Koifmann, A | 1 |
Giat, Y | 1 |
Levy, J | 1 |
Sharoni, Y | 1 |
Rust, WL | 1 |
Huff, JL | 1 |
Plopper, GE | 1 |
Benbow, U | 1 |
Orndorff, KA | 1 |
Brinckerhoff, CE | 1 |
Givan, AL | 1 |
Bedner, E | 1 |
Ruan, Q | 1 |
Chen, S | 1 |
Kamentsky, LA | 1 |
Darzynkiewicz, Z | 2 |
Stomper, PC | 1 |
DeBloom, JR | 1 |
Winston, JS | 1 |
Stewart, CC | 1 |
Lilling, G | 1 |
Nordenberg, J | 1 |
Rotter, V | 1 |
Goldfinger, N | 1 |
Peller, S | 1 |
Sidi, Y | 1 |
Myc, A | 1 |
Traganos, F | 1 |
Lara, J | 1 |
Melamed, MR | 1 |
Bach, BA | 1 |
Knape, WA | 1 |
Edinger, MG | 1 |
Tubbs, RR | 1 |
Prey, MU | 1 |
Meyer, JS | 1 |
Stone, KR | 1 |
McDivitt, RW | 1 |
31 other studies available for propidium and Breast Cancer
Article | Year |
---|---|
Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Fluoresceins; Fluorescent Dyes; High-Thro | 2022 |
The antiproliferative and apoptotic potential of Clinacanthus nutans against human breast cancer cells through targeted apoptosis pathway.
Topics: Acanthaceae; Annexin A5; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Caspase | 2022 |
Combined Anastrozole and Antiplatelet Therapy Treatment Differentially Promotes Breast Cancer Cell Survival.
Topics: Anastrozole; Annexin A5; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Humans; MCF-7 | 2020 |
Docking and molecular dynamics predicted B-DNA and dihydropyrimidinone selenoesters interactions elucidating antiproliferative effects on breast adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; DNA; DNA, B-Form; Female; Humans; Ligands; | 2022 |
Cytotoxic effect of ethanol extract of microalga, Chaetoceros calcitrans, and its mechanisms in inducing apoptosis in human breast cancer cell line.
Topics: Annexin A5; Apoptosis; Biological Products; Breast Neoplasms; Cell Cycle; Cell Proliferation; Ethano | 2013 |
Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.
Topics: Aluminum Silicates; Animals; Annexin A5; Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasm | 2014 |
Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide.
Topics: Acetazolamide; Annexin A5; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; De | 2014 |
Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγ.
Topics: Analysis of Variance; Annexin A5; Antineoplastic Agents; Apoptosis; Azo Compounds; Blotting, Western | 2014 |
Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
Topics: Annexin A5; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cyclin D1; Female; Gene Exp | 2015 |
Microdevice for analyzing the effect of electrochemotherapy on cancer cells.
Topics: Bleomycin; Breast Neoplasms; Carcinoma, Ductal; Cell Line, Tumor; Cell Proliferation; Electrochemoth | 2009 |
G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
Topics: Adenocarcinoma; Antimetabolites; Antimetabolites, Antineoplastic; Breast Neoplasms; Bromodeoxyuridin | 2002 |
Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7).
Topics: Breast Neoplasms; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent A | 2002 |
Laser-assisted microinjection into targeted animal cells.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Membrane Permeability; Cell Survival; Drug Delivery Systems; | 2003 |
Cytostatic and cytotoxic effects of alkylglycerols (Ecomer).
Topics: Alkanes; Annexin A5; Apoptosis; Breast Neoplasms; Cell Division; Cell Line, Tumor; Coloring Agents; | 2003 |
Isolation of high quality mRNA from a discrete cell cycle population identified using a nonvital dye and fluorescence activated sorting.
Topics: Breast Neoplasms; Cell Cycle; Cell Separation; DNA; Flow Cytometry; Humans; Lysophosphatidylcholines | 1993 |
Flow cytometric analysis of DNA and nuclear protein in paraffin-embedded tissue.
Topics: Aneuploidy; Breast Neoplasms; Carcinoma; Cell Separation; Colonic Neoplasms; DNA; Flow Cytometry; Fl | 1993 |
Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Apoptosis; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; | 1995 |
Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Hypoxia; Cell Separation; Cell Survival; DNA, Neoplasm; E | 1997 |
Anti-estrogens induce apoptosis of multiple myeloma cells.
Topics: Apoptosis; Breast Neoplasms; Cell Division; Cell Survival; Coloring Agents; Estradiol; Estrogen Anta | 1998 |
Heat pretreatment increases resolution in DNA flow cytometry of paraffin-embedded tumor tissue.
Topics: Breast Neoplasms; Cell Separation; Colon; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fl | 1999 |
Flow cytometric analysis of estrogen receptor expression in isolated nuclei and cells from mammary cancer tissues.
Topics: Breast Neoplasms; DNA; Endopeptidases; Female; Flow Cytometry; Humans; Immunohistochemistry; Lymphoc | 1999 |
Energy transfer between fluorescein isothiocyanate and propidium iodide--a problem in the estimation of Tpot with the bromodeoxyuridine-DNA flow cytometry technique?
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antimetabolites; Breast Neoplasms; Bromodeoxyuridin | 1999 |
Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Carotenoids; Cell Cycle; Cell Death; Cell Division; Color | 2000 |
Screening assay for promigratory/antimigratory compounds.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Screening Assays, Antitumor; Fluoresceins; Fluorescent | 2000 |
Confocal assay for invasion: use of propidium iodide fluorescence and laser reflectance to quantify the rate of migration of cells through a matrix.
Topics: Breast Neoplasms; Cell Movement; Diagnostic Imaging; DNA, Neoplasm; Female; Fluorescence; Humans; In | 2000 |
Multiparameter analysis of progeny of individual cells by laser scanning cytometry.
Topics: Boron Compounds; Breast Neoplasms; Carrier Proteins; Cell Cycle; DNA, Neoplasm; Egg Proteins; Female | 2000 |
Flow cytometric DNA analysis of specimen mammography-guided fine-needle aspirates of ductal carcinoma in situ.
Topics: Adult; Aged; Aged, 80 and over; Aneuploidy; Apoptosis; Biopsy, Needle; Breast Neoplasms; Carcinoma, | 2000 |
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Northern; Blotting, Western; Breast Neoplasms; | 2002 |
DNA stainability in aneuploid breast tumors: comparison of four DNA fluorochromes differing in binding properties.
Topics: Acridine Orange; Adult; Aged; Aneuploidy; Benzimidazoles; Breast Neoplasms; Carcinoma, Intraductal, | 1992 |
Improved sensitivity and resolution in the flow cytometric DNA analysis of human solid tumor specimens. Use of in vitro fine-needle aspiration and uniform staining reagents.
Topics: Aneuploidy; Biopsy, Needle; Breast Neoplasms; Colonic Neoplasms; DNA, Neoplasm; Flow Cytometry; Fluo | 1991 |
Heterogeneity of breast carcinomas determined by flow cytometric analysis.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Female; Flow Cytometry; Humans; Lymphatic Metastasis; Middle | 1985 |